1 |
Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 2012; 15: 635-45.
|
2 |
Huang S, Rutkowsky JM, Snodgrass RG. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res 2012; 53: 2002-13.
|
3 |
Fessler MB, Rudel LL, Brown JM. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol 2009; 20: 379-85.
|
4 |
Shi H, Kokoeva MV, Inouye K, et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-25.
|
5 |
Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007; 56: 1986-98.
|
6 |
Radin MS, Sinha S, Bhatt BA, et al. Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 2008; 51: 336-46.
|
7 |
Zhao L, Kwon MJ, Huang S, et al. Differential modulation of Nods signalling pathways by fatty acids in human colonial epithelial HCT116 cells. J Biol Chem 2007; 282: 11618-28.
|
8 |
Zhao L, Hu P, Zhou Y. NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2011; 301: E587-98.
|
9 |
Zhou YJ, Li A, Song YL, et al. Nucleotide-binding oligo- merization domain-1 ligand induces inflammation and attenuates glucose uptake in human adipocytes. Chin Med Sci J 2012; 27: 147-52.
|
1 |
0.Zhou YJ, Zhou H, Li Y, et al. NOD1 activation induces innate immune responses and insulin resistance in human adipocytes. Diabetes Metab 2012; 38: 538-43.
|
|
1.An Y, Liu K, Zhou Y, et al. Salicylate inhibits macrophage-secreted factors induced adipocyte inflammation and changes of adipokines in 3T3-L1 adipocytes. Inflammation 2009; 32: 296-303.
|
|
2.Pfaffl MW. A new mathematical model for relative quantifi- cation in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
|
|
3.Cuda C, Badawi A, Karmali M, et al. Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes. Genes Nutr 2012; 7: 427-35.
|
|
4.Khan PM, Correa RG, Divlianska DB, et al. Identification of inhibitors of NOD1-induced nuclear factor-κB acti- vation. ACS Med Chem Lett 2011; 2: 780-5.
|
|
5.Schertzer JD, Tamrakar AK, Magalhães JG, et al. NOD1 activators link innate immunity to insulin resistance. Diabetes 2011; 60: 2206-15.
|
|
6.Schertzer JD, Klip A. Give a NOD to insulin resistance. Am J Physiol Endocrinol Metab 2011; 301: E585-6.
|
|
7.Kamei N, Tobe K, Suzuki R, et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006; 281: 26602-14.
|
|
8.Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-505.
|
|
9.Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin resistant subjects. J Biol Chem 2003; 278: 45777-84.
|
2 |
0.Stienstra R, van Diepen JA, Tack CJ, et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA 2011; 108: 15324-9.
|